Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)

This study has been completed.
Sponsor:
Information provided by:
Osaka University
ClinicalTrials.gov Identifier:
NCT00298870
First received: March 2, 2006
Last updated: October 17, 2012
Last verified: May 2011